SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel

Post author:admin
Post published:July 8, 2025
Post category:uncategorized

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of a peer-reviewed study in the International Wound Journal.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Modern farming waste carries emerging contaminants that threaten ecosystems and health

Triaptosis-based therapeutic innovations could offer renewed hope for cancer patients

Study could lead to non-invasive, light-based techniques for early detection of skin conditions

Helpful Links

Subscribe To Us